Efficacy of immune checkpoint inhibitors according to programmed cell death‐ligand 1 expression in patients with non‐small cell lung cancer and brain metastasis: A real‐world prospective observational study.

Autor: Masuda, Takeshi1 (AUTHOR) ta-masuda@hiroshima-u.ac.jp, Tsubata, Yukari2 (AUTHOR), Hata, Kojirou2 (AUTHOR), Horie, Mika2 (AUTHOR), Kiura, Katsuyuki3 (AUTHOR), Kanaji, Nobuhiro4 (AUTHOR), Inoue, Takuya4 (AUTHOR), Kodani, Masahiro5 (AUTHOR), Yanai, Masaaki5 (AUTHOR), Yamaguchi, Kakuhiro1 (AUTHOR), Matsumoto, Naoko6 (AUTHOR), Yamasaki, Masahiro6 (AUTHOR), Ishikawa, Nobuhisa7 (AUTHOR), Masuda, Ken7 (AUTHOR), Takigawa, Nagio8 (AUTHOR), Kuyama, Shoichi9 (AUTHOR), Kubota, Tetsuya10 (AUTHOR), Nishii, Kazuya9 (AUTHOR), Hotta, Katsuyuki11 (AUTHOR), Hattori, Noboru1 (AUTHOR)
Zdroj: Thoracic Cancer. Dec2024, Vol. 15 Issue 34, p2408-2417. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje